RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is ...
A digital therapeutic (DTx) for attention deficit hyperactivity disorder (ADHD) developed by Akili has been approved in Japan, where it will be sold by licensee Shionogi. The DTx – known as ...